The study will involve approximately 120 menstruating adult women who are experiencing symptoms of menstrual pain and discomfort.
Starting the Study: Following enrolment, you will be allocated and sent your study product. Before you start taking your trial product, you will be required to record baseline information for one menstrual period. This will involve:
- A pre-menstrual symptom questionnaire on Day 1 (first day of bleeding)
- A pain score and menstrual symptom questionnaire on each day of your menstrual period.
Once you have completed and scored your first menstrual period, you can start to take the supplied trial product daily as directed.
During the Study: You will take the trial product daily as directed until you have completed a further 3 menstrual periods (approximately 3 months). As with the baseline information, you will be required to complete a pre-menstrual symptom questionnaire on Day 1, and a daily questionnaire during each period. If required, you may take additional pain medication; however, this must be recorded in your daily questionnaire.
All data will be entered online using your unique Participant ID. There is no need to attend any interviews or appointments in person.
The information we collect during the study, including if you took any other additional pain medication, will enable the investigators to assess the product’s effectiveness on improving menstrual pain and discomfort.
If you’re a woman experiencing symptoms of menstrual pain, aged between 18 and 50, and would like to help, we’d love to hear from you. Please register your interest by answering the questionnaire and completing the form on this page… we’ll then get in touch to screen you for suitability.